EurekaMag.com logo
+ Translate

Evidence of interferon production in the hamster lung after primary or secondary exposure to parainfluenza virus type 3


, : Evidence of interferon production in the hamster lung after primary or secondary exposure to parainfluenza virus type 3. American Review of Respiratory Disease 125(6): 706-711

Experimental infection of the hamster respiratory tract with parainfluenza virus type 3 has been used to study the pathogenesis of viral pneumonia and the host response to infection. In this study, hamsters inoculated intranasally with parainfluenza virus type 3 produced local interferon, which was detected in lung washes obtained by in situ lavage. Interferon activity was present as early as 2 days after infection, and titers correlated directly with the quantity of virus recovered in lung washes. Parainfluenza virus type 3 was sensitive to the antiviral state induced in vitro by the lung wash interferon. Infectious virus induced interferon in cultures of immune and nonimmune lung wash cells, primarily alveolar macrophages. A secondary response of immune, mixed cultures of lymphocytes and alveolar macrophages, stimulated with inactivated virus, produced low concentrations of interferon, perhaps type II. Lymphocyte-alveolar macrophage cultures produced a pH and temperature-sensitive interferon in response to mitogen induction, characteristics of type II or immune interferons in the human and murine systems. Interferon may be an early defense involved in recovery from primary infection with parainfluenza virus type 3, and may contribute to resistance to reinfection.

(PDF same-day service: $19.90)

Accession: 005411529

PMID: 6178328

DOI: 10.1164/arrd.1982.125.6.706

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Frickey, P.H., 1969: Markers differentiating type 3 parainfluenza virus grown at 25 and 37 c cercopithecus monkey kidney tissue culture hamster interferon production hem agglutination inhibition antibodies. Applied Microbiology 17(4): 589-595

Craighead, John E., 1966: Growth of parainfluenza type 3 virus and interferon production in infant and adult mice. Intranasal inoculation of newborn mice with parainfluenza type 3 virus resulted in infections of the nasal turbinates for as long as 18 to 21 days, and of the lungs for up to 12 days. Growth of virus in the respiratory tracts of older mice was mor...

Krilov L.; Godfrey E.; Mcintosh K., 1985: Interferon production by monocyte macrophages in response to respiratory syncytial virus and parainfluenza type 3. Pediatric Research 19(4 PART 2): 298A

Komatsu, T.; Takeuchi, K.; Gotoh, B., 2007: Bovine parainfluenza virus type 3 accessory proteins that suppress beta interferon production. The paramyxovirus P gene encodes accessory proteins antagonistic to interferon (IFN). Viral proteins responsible for the IFN antagonism, however, are distinct among paramyxoviruses. Here we determine bovine parainfluenza virus type 3 (bPIV3) IFN...

Kibler, R.; Solvay, M.J.; ter Meulen, V., 1978: Cell-mediated cytotoxicity: comparison of primary and secondary immune reactions after parainfluenza type 1 virus inoculation. H-2 antigen compatibility of effector spleen cells and target cells was necessary for cell-mediated cytotoxicity (CMC) after both 1 and 2 intraperitoneal inoculation of 6/94 virus into mice. T cells were responsible for both primary and secondary...

Schaap-Nutt, A.; D'Angelo, C.; Scull, M.A.; Amaro-Carambot, E.; Nishio, M.; Pickles, R.J.; Collins, P.L.; Murphy, B.R.; Schmidt, A.C., 2010: Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates. In wild-type human parainfluenza virus type 2 (WT HPIV2), one gene (the P/V gene) encodes both the polymerase-associated phosphoprotein (P) and the accessory V protein. We generated a HPIV2 virus (rHPIV2-V<sup>ko</sup>) in which the P/...

Crookshanks Newman F.K.; Belshe R.B., 1985: Protection from experimental wild type parainfluenza virus type 3 infection by cold adapted mutants of parainfluenza virus type 3 in weanling hamsters. Abstracts of the Annual Meeting of the American Society for Microbiology 85: 298

Crookshanks Newman F.K.; Belshe R.B., 1986: Protection of weanling hamsters from experimental infection with wild type parainfluenza virus type 3 by cold adapted mutants of parainfluenza virus type 3. Parainfluenza virus type 3 (para 3) was adapted to replicate at 20.degree. C, a nonpermissive temperature for wild-type (wt) para 3. Serial passage at 20.degree.C resulted in the generations of cold-adapted (ca) and temperature-sensitive (ts) muta...

Haller, A.A.; Miller, T.; Mitiku, M.; Coelingh, K., 2000: Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector. Bovine parainfluenza virus type 3 (bPIV3) is being evaluated as an intranasal vaccine for protection against human PIV3 (hPIV3). In young infants, the bPIV3 vaccine appears to be infectious, attenuated, immunogenic and genetically stable, which ar...

Hall, C.B.; Douglas, R.G.J. ; Simons, R.L.; Geiman, J.M., 1978: Interferon production in children with respiratory syncytial virus influenza virus and parainfluenza virus infections. To better understand the recovery process of infants with lower respiratory tract disease due to respiratory syncytial virus [RSV], the production of interferon by 129 children (ages 10 days-24 mo.) with RSV infection was compared to that of 20 ch...